|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/706 | (2006.01) |
| A61K 31/708 | (2006.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/245 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2914254 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13851971.5 |
| Date of filing the European patent application | 2013-10-30 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation | 2020-04-27 |
| (86) | Number | PCT/US2013/067607 |
| Date | 2013-10-30 |
| (87) | Number | WO 2014/070948 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| 201261720346 P | 2012-10-30 | US |
| (72) |
GOLD, Daniel, P., US
GARCIA-MANERO, Guillermo, US
|
| (73) |
MEI Pharma, Inc.,
11975 El Camino Real, Suite 101, San Diego, CA 92130,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kombinacinės terapijos chemoresistencinių vėžių gydymui |
| COMBINATION THERAPIES TO TREAT CHEMORESISTANT CANCERS |
| Payment date | Validity (years) | Amount | |
| 2021-10-04 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-10-30 |